278 related articles for article (PubMed ID: 25288727)
1. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
Lin Y; Zhang H; Liang J; Li K; Zhu W; Fu L; Wang F; Zheng X; Shi H; Wu S; Xiao X; Chen L; Tang L; Yan M; Yang X; Tan Y; Qiu P; Huang Y; Yin W; Su X; Hu H; Hu J; Yan G
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4504-12. PubMed ID: 25288727
[TBL] [Abstract][Full Text] [Related]
2. A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
Li K; Liang J; Lin Y; Zhang H; Xiao X; Tan Y; Cai J; Zhu W; Xing F; Hu J; Yan G
Oncotarget; 2016 Jul; 7(30):48443-48455. PubMed ID: 27374176
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
4. A mathematical model verifying potent oncolytic efficacy of M1 virus.
Wang Z; Guo Z; Peng H
Math Biosci; 2016 Jun; 276():19-27. PubMed ID: 26976483
[TBL] [Abstract][Full Text] [Related]
5. Liposome Encapsulation of Oncolytic Virus M1 To Reduce Immunogenicity and Immune Clearance in Vivo.
Wang Y; Huang H; Zou H; Tian X; Hu J; Qiu P; Hu H; Yan G
Mol Pharm; 2019 Feb; 16(2):779-785. PubMed ID: 30604617
[TBL] [Abstract][Full Text] [Related]
6. Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
Hu C; Liu Y; Lin Y; Liang JK; Zhong WW; Li K; Huang WT; Wang DJ; Yan GM; Zhu WB; Qiu JG; Gao X
Cell Death Dis; 2018 Feb; 9(3):274. PubMed ID: 29449555
[TBL] [Abstract][Full Text] [Related]
7. Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
Liu Y; Li K; Zhu WB; Zhang H; Huang WT; Liu XC; Lin Y; Cai J; Yan GM; Qiu JG; Peng L; Liang JK; Hu C
Neoplasia; 2021 Jan; 23(1):158-168. PubMed ID: 33338804
[TBL] [Abstract][Full Text] [Related]
8. Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells.
Dan J; Nie L; Jia X; Xu C; Cai J; Lin Y; Hu J; Zhu W; Li Y; Chen D; Liu Y; Hu C; Yan G; Liang J; Zhang Q
Virol Sin; 2021 Aug; 36(4):655-666. PubMed ID: 33481190
[TBL] [Abstract][Full Text] [Related]
9. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.
Li K; Zhang H; Qiu J; Lin Y; Liang J; Xiao X; Fu L; Wang F; Cai J; Tan Y; Zhu W; Yin W; Lu B; Xing F; Tang L; Yan M; Mai J; Li Y; Chen W; Qiu P; Su X; Gao G; Tai PW; Hu J; Yan G
Mol Ther; 2016 Feb; 24(1):156-65. PubMed ID: 26373347
[TBL] [Abstract][Full Text] [Related]
10. The Identification and Development of a Novel Oncolytic Virus: Alphavirus M1.
Cai J; Yan G
Hum Gene Ther; 2021 Feb; 32(3-4):138-149. PubMed ID: 33261513
[TBL] [Abstract][Full Text] [Related]
11. Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
Cai J; Lin K; Cai W; Lin Y; Liu X; Guo L; Zhang J; Xu W; Lin Z; Wong CW; Sander M; Hu J; Yan G; Zhu W; Liang J
Mol Oncol; 2020 Dec; 14(12):3153-3168. PubMed ID: 33037696
[TBL] [Abstract][Full Text] [Related]
12. Systematic Characterization of the Biodistribution of the Oncolytic Virus M1.
Cai J; Zhu W; Lin Y; Zhang S; Chen X; Gong S; He S; Hu J; Yan G; Liang J
Hum Gene Ther; 2020 Nov; 31(21-22):1203-1213. PubMed ID: 32829653
[TBL] [Abstract][Full Text] [Related]
13. Real-Time Visualization and Quantification of Oncolytic M1 Virus
Zhu W; Liang J; Tan J; Guo L; Cai J; Hu J; Yan G; Liu Y; Zhang J; Song D; Dan J; Wong CW; Su X; Qiu P; Lin Y
Hum Gene Ther; 2021 Feb; 32(3-4):158-165. PubMed ID: 33504253
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
[TBL] [Abstract][Full Text] [Related]
15. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
16. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
Tan Y; Lin Y; Li K; Xiao X; Liang J; Cai J; Guo L; Li C; Zhu W; Xing F; Mai J; Gu J; Tan X; Yin W; Lu B; Qiu P; Su X; Gao M; Hu J; He S; Lu L; Gong S; Yan G; Zhang H
Hum Gene Ther; 2018 Aug; 29(8):950-961. PubMed ID: 28750564
[TBL] [Abstract][Full Text] [Related]
17. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.
Wang Z; Yu B; Wang B; Yan J; Feng X; Wang Z; Wang L; Zhang H; Wu H; Wu J; Kong W; Yu X
Oncotarget; 2016 Jul; 7(30):47287-47301. PubMed ID: 27323824
[TBL] [Abstract][Full Text] [Related]
18. Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics.
Cai J; Lin Y; Zhang H; Liang J; Tan Y; Cavenee WK; Yan G
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6812-6817. PubMed ID: 28607091
[TBL] [Abstract][Full Text] [Related]
19. DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Xiao X; Liang J; Huang C; Li K; Xing F; Zhu W; Lin Z; Xu W; Wu G; Zhang J; Lin X; Tan Y; Cai J; Hu J; Chen X; Huang Y; Qin Z; Qiu P; Su X; Chen L; Lin Y; Zhang H; Yan G
Nat Commun; 2018 Oct; 9(1):4342. PubMed ID: 30337542
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus.
Liang J; Guo L; Li K; Xiao X; Zhu W; Zheng X; Hu J; Zhang H; Cai J; Yu Y; Tan Y; Li C; Liu X; Hu C; Liu Y; Qiu P; Su X; He S; Lin Y; Yan G
Nat Commun; 2018 Apr; 9(1):1524. PubMed ID: 29670091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
